Pfizer Leads An Unusual Year For The Scrip 100

Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.      

Leading the way
• Source: Shutterstock

It was an unusual year for the Scrip 100 rankings as revenues from the sale of vaccines and treatments for COVID-19 skewed the leaderboard in ways that could not have been anticipated before the virus emerged in 2020 and sparked a global health crisis.

Pfizer Inc. reclaimed the number one spot in the drug company rankings based on 2021 pharmaceutical revenues, while two...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Outlook Archive

More from Outlook